{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T08:24:46Z","timestamp":1792571086266,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T00:00:00Z","timestamp":1525219200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13075-018-1585-0","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T12:43:13Z","timestamp":1525264993000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Accuracy of the HumaSensplus point-of-care uric acid meter using capillary blood obtained by fingertip puncture"],"prefix":"10.1186","volume":"20","author":[{"given":"St\u00e9phanie","family":"Fabre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Clerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marie","family":"Launay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Gautier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiphaine","family":"Vidal-Trecan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Riveline","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Platt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Abrahamsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey N.","family":"Miner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glen","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Richette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Bardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,2]]},"reference":[{"key":"1585_CR1","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/nrrheum.2015.91","volume":"11","author":"C-F Kuo","year":"2015","unstructured":"Kuo C-F, Grainge MJ, Zhang W, Doherty M. Global epidemiology of gout: prevalence, incidence and risk factors. Nat Rev Rheumatol. 2015;11:649\u201362.","journal-title":"Nat Rev Rheumatol"},{"issue":"10055","key":"1585_CR2","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1016\/S0140-6736(16)00346-9","volume":"388","author":"Nicola Dalbeth","year":"2016","unstructured":"Dalbeth N, Merriman TR, Stamp LK. Gout and the journal Lancet. Lancet Lond Engl. 2016;388:2039\u201352.","journal-title":"The Lancet"},{"key":"1585_CR3","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/1477-7525-10-117","volume":"10","author":"PP Khanna","year":"2012","unstructured":"Khanna PP, Nuki G, Bardin T, Tausche A-K, Forsythe A, Goren A, et al. Tophi and frequent gout flares are associated with impairments to quality of life, productivity, and increased healthcare resource use: results from a cross-sectional survey. Health Qual Life Outcomes. 2012;10:117.","journal-title":"Health Qual Life Outcomes"},{"key":"1585_CR4","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/nrrheum.2014.124","volume":"10","author":"P Richette","year":"2014","unstructured":"Richette P, Perez-Ruiz F, Doherty M, Jansen TL, Nuki G, Pascual E, et al. Improving cardiovascular and renal outcomes in gout: what should we target? Nat Rev Rheumatol. 2014;10:654\u201361.","journal-title":"Nat Rev Rheumatol"},{"key":"1585_CR5","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1002\/acr.21772","volume":"64","author":"D Khanna","year":"2012","unstructured":"Khanna D, Fitzgerald JD, Khanna PP, Bae S, Singh MK, Neogi T, et al. American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res. 2012;64:1431\u201346.","journal-title":"Arthritis Care Res"},{"key":"1585_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","volume":"76","author":"P Richette","year":"2017","unstructured":"Richette P, Doherty M, Pascual E, Barskova V, Becce F, Casta\u00f1eda-Sanabria J, et al. 2016 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis. 2017;76:29\u201342.","journal-title":"Ann Rheum Dis"},{"key":"1585_CR7","first-page":"1056","volume":"56","author":"M Hui","year":"2017","unstructured":"Hui M, Carr A, Cameron S, Davenport G, Doherty M, Forrester H, et al. The British Society for Rheumatology guideline for the management of gout. Rheumatol Oxf. Engl. 2017;56:1056\u20139.","journal-title":"Engl"},{"key":"1585_CR8","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/0009-8981(80)90257-0","volume":"101","author":"GT Sanders","year":"1980","unstructured":"Sanders GT, Pasman AJ, Hoek FJ. Determination of uric acid with uricase and peroxidase. Clin Chim Acta. 1980;101:299\u2013303.","journal-title":"Clin Chim Acta"},{"key":"1585_CR9","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.jbspin.2011.05.010","volume":"78","author":"G Reach","year":"2011","unstructured":"Reach G. Treatment adherence in patients with gout. Joint Bone Spine. 2011;78:456\u20139.","journal-title":"Joint Bone Spine"},{"key":"1585_CR10","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1586\/14737159.2016.1134326","volume":"16","author":"J Paraskos","year":"2016","unstructured":"Paraskos J, Berke Z, Cook J, Miner JN, Braddock M, Platt A, et al. An analytical comparison between point-of-care uric acid testing meters. Expert Rev Mol Diagn. 2016;16:373\u201382.","journal-title":"Expert Rev Mol Diagn"},{"key":"1585_CR11","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/S0021-9673(00)81023-7","volume":"149","author":"CK Lim","year":"1978","unstructured":"Lim CK, Pryde DE, Lawson AM. Specific method for determining uric acid in serum using high-performance liquid chromatography and gas chromatography-mass spectropmetry. J Chromatogr. 1978;149:711\u201320.","journal-title":"J Chromatogr"},{"issue":"1","key":"1585_CR12","doi-asserted-by":"publisher","first-page":"255","DOI":"10.2307\/2532051","volume":"45","author":"Lawrence I-Kuei Lin","year":"1989","unstructured":"Lin LI. A concordance correlation coefficient to evaluate reproducibility. Biometrics. 1989;45:255\u201368.","journal-title":"Biometrics"},{"key":"1585_CR13","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.theriogenology.2010.01.003","volume":"73","author":"PF Watson","year":"2010","unstructured":"Watson PF, Petrie A. Method agreement analysis: a review of correct methodology. Theriogenology. 2010;73:1167\u201379.","journal-title":"Theriogenology"},{"key":"1585_CR14","unstructured":"International Organization\u00a0 for Standardisation.\u00a0In vitrodiagnostic test systems\u2014requirements for blood glucose monitoring systems for self-testing in managing diabetes mellitus.DIN EN ISO15197. 2003."},{"key":"1585_CR15","unstructured":"International\u00a0Organization\u00a0 for\u00a0Standardisation.\u00a0In vitrodiagnostic test systems\u2014requirements for blood glucose monitoring systems for self-testing in managing diabetes mellitus.DIN EN ISO15197. 2013.\u00a0"},{"issue":"Suppl 2","key":"1585_CR16","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1136\/annrheumdis-2015-eular.5007","volume":"74","author":"J Nuevo","year":"2015","unstructured":"Nuevo J, Nyberg F, Home L. Evaluation of the impact of current treatment on the evolution of serum urate profile, gout flares, and tophi in patients with gout in France, Germany, United Kingdom, and the United State (ICARUS study). Ann Rheum Dis. 2015;74(Suppl 2):549\u201350.","journal-title":"Ann Rheum Dis"},{"key":"1585_CR17","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.semarthrit.2015.05.005","volume":"45","author":"MA Becker","year":"2015","unstructured":"Becker MA, Fitz-Patrick D, Choi HK, Dalbeth N, Storgard C, Cravets M, et al. An open-label, 6-month study of allopurinol safety in gout: the LASSO study. Semin Arthritis Rheum. 2015;45:174\u201383.","journal-title":"Semin Arthritis Rheum"},{"key":"1585_CR18","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1185\/03007990903017966","volume":"25","author":"R Halpern","year":"2009","unstructured":"Halpern R, Mody RR, Fuldeore MJ, Patel PA, Mikuls TR. Impact of noncompliance with urate-lowering drug on serum urate and gout-related healthcare costs: administrative claims analysis. Curr Med Res Opin. 2009;25:1711\u20139.","journal-title":"Curr Med Res Opin"},{"key":"1585_CR19","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.3899\/jrheum.080487","volume":"36","author":"EQ Wu","year":"2009","unstructured":"Wu EQ, Patel PA, Mody RR, Yu AP, Cahill KE, Tang J, et al. Frequency, risk, and cost of gout-related episodes among the elderly: does serum uric acid level matter. J Rheumatol. 2009;36:1032\u201340.","journal-title":"J Rheumatol"},{"key":"1585_CR20","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1097\/RHU.0000000000000322","volume":"21","author":"A Altan","year":"2015","unstructured":"Altan A, Shiozawa A, Bancroft T, Singh JA. A real-world study of switching from allopurinol to febuxostat in a health plan database. J Clin Rheumatol. 2015;21:411\u20138.","journal-title":"J Clin Rheumatol"},{"key":"1585_CR21","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1177\/1932296815608869","volume":"10","author":"S Harashima","year":"2015","unstructured":"Harashima S, Nishimura A, Ikeda K, Wang Y, Liu Y, Inagaki N. Once daily self-monitoring of blood glucose (SMBG) improves glycemic control in oral hypoglycemic agents (OHA)-treated diabetes. J Diabetes Sci Technol. 2015;10:378\u201382.","journal-title":"J Diabetes Sci Technol"},{"key":"1585_CR22","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.2337\/diacare.22.11.1785","volume":"22","author":"E Cagliero","year":"1999","unstructured":"Cagliero E, Levina EV, Nathan DM. Immediate feedback of HbA1c levels improves glycemic control in type 1 and insulin-treated type 2 diabetic patients. Diabetes Care. 1999;22:1785\u20139.","journal-title":"Diabetes Care"},{"key":"1585_CR23","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1001\/jama.281.2.145","volume":"281","author":"PT Sawicki","year":"1999","unstructured":"Sawicki PT. A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation. JAMA. 1999;281:145\u201350.","journal-title":"JAMA"},{"key":"1585_CR24","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1136\/annrheumdis-2012-201795","volume":"72","author":"MA Becker","year":"2013","unstructured":"Becker MA, Baraf HSB, Yood RA, Dillon A, V\u00e1zquez-Mellado J, Ottery FD, et al. Long-term safety of pegloticase in chronic gout refractory to conventional treatment. Ann Rheum Dis. 2013;72:1469\u201374.","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 2","key":"1585_CR25","first-page":"282","volume":"76","author":"T Bardin","year":"2017","unstructured":"Bardin T, Magnat E, Clerson P, Richette P, Rouchon B. Epidemiology of gout and hyperuricemia in New Caledonia. Ann Rheum Dis. 2017;76(Suppl 2):282\u20133.","journal-title":"Ann Rheum Dis"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-018-1585-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-018-1585-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-018-1585-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T01:57:47Z","timestamp":1751594267000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-018-1585-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,2]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1585"],"URL":"https:\/\/doi.org\/10.1186\/s13075-018-1585-0","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,2]]},"assertion":[{"value":"30 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the ethics committee of Paris 7 university. Patients received a written information sheet with details on the study. All gave informed consent before any study procedure. A subset of patients agreed to sign a specific informed consent for LC-MS measurement.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"AA, AP, and GH are employees of AstraZeneca, and JNM was an employee of Ardea Biosciences, a wholly owned subsidiary of AstraZeneca at the time of this work. The other authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"78"}}